文献速递腹部介入技术与安全US

携带HSV-TK基因的纳米靶向阳离子脂质微泡在HIFU消融后抑制皮下肝肿瘤模型的发展

Nanotargeted Cationic Lipid Microbubbles Carrying HSV-TK Gene Inhibit the Development of Subcutaneous Liver Tumor Model After HIFU Ablation.
PubMed 文献 · J Ultrasound Med · 2023-10-10

本研究构建了链接GPC3抗体与HSV-TK质粒的阳离子微泡(CMB),验证其体外靶向肝癌细胞并高效转染HSV-TK,对肝癌细胞增殖和侵袭有显著抑制作用;动物体内实验显示该微泡具有良好靶向性,HSV-TK/GCV系统启动细胞死亡,增强HIFU治疗效果,可靶向并杀伤HIFU消融后残留的皮下肝肿瘤细胞。

要点

  • 阳离子微泡(CMB)成功链接GPC3与HSV-TK质粒,构建靶向基因携带微泡。
  • 该微泡可特异结合肝癌细胞,HSV-TK转染效率高,显著抑制肝癌细胞增殖和侵袭。
  • 动物体内靶向性好,HSV-TK/GCV系统启动细胞死亡,增强HIFU治疗效果。

核心结论

  • CMB联合GPC3抗体与HSV-TK质粒可在GPC3抗体引导下靶向HIFU消融后残留的皮下肝肿瘤细胞,并在超声作用下杀伤残留细胞,从而增强HIFU对肝癌的治疗效果。

研究设计与样本

  • 实验研究:构建链接GPC3与HSV-TK质粒的阳离子微泡(CMB),进行体外细胞实验与动物体内实验,评估靶向性、转染效率及对HIFU治疗的增强作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: High-intensity focused ultrasound (HIFU) has been widely used in clinical settings and has achieved suitable results in the treatment of many cancerous or noncancerous diseases. However, in the treatment of liver cancer, because the tumor is located deep within the liver tissue, when ultrasound penetrates the tissue, it will inevitably produce sound energy attenuation. This attenuation limits the reliability of HIFU treatment, reduce the efficacy of HIFU, and increase the risk of tumor recurrence.

METHODS: Cationic microbubbles (CMB) were successfully linked with GPC3 and HSV-TK plasmids, and targeted gene-carrying CMB were successfully constructed. Moreover, the gene-targeted cation microbubbles had suitable targeting and can specifically bind with liver cancer cells.

RESULTS: The HSV-TK transfection efficiency was high and had a significant inhibitory effect on the proliferation and invasion of liver cancer cells. After the gene-carrying cation microbubbles entered the animal body, they had a great targeting effect in vivo. They transfected the target genes into liver cancer cells, and the HSV-TK/GCV system initiated cell death, demonstrating that these targeted microbubbles, enhanced HIFU treatment.

CONCLUSIONS: Overall, CMB combined with a GPC3 antibody and HSV-TK plasmid can target residual subcutaneous liver tumor cells under the guidance of GPC3 antibody, and kill residual subcutaneous liver tumor cells under the action of ultrasound, thus enhancing the therapeutic effect of HIFU on liver cancer.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Liu Y, Zhang Y, Du D, et al. Nanotargeted Cationic Lipid Microbubbles Carrying HSV-TK Gene Inhibit the Development of Subcutaneous Liver Tumor Model After HIFU Ablation. J Ultrasound Med. 2023. PMID: 37815381. doi:10.1002/jum.16342

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。